Papers
1
Total Citations
16
H-Index
1
About
Yao Cen is a rising innovator at the intersection of synthetic biology and biosensing, whose work focuses on harnessing and controlling CRISPR/Cas12a systems for next-generation molecular diagnostics. Their key research areas include CRISPR-based biosensor design, DNA nanotechnology, and the engineering of programmable molecular tools for healthcare applications. Cen’s major contribution lies in developing “DNA robots” that can precisely manage the trans-cleavage activity of Cas12a—a critical challenge in the field. By creating simple yet powerful modifications, they have unlocked universal platforms for biosensing that are both highly sensitive and adaptable to diverse targets. Their 2024 paper on this topic has already garnered 16 citations, signaling strong early impact and interest from the scientific community. This work addresses a long-standing bottleneck in CRISPR diagnostics: the difficulty of controlling Cas12a’s off-target activity without complex redesigns. Cen’s approach offers a modular, scalable solution that could accelerate the development of point-of-care tests for infectious diseases, genetic markers, and beyond. With a clear talent for merging fundamental enzymology with applied nanotechnology, Yao Cen is establishing themselves as a key architect of the next generation of smart, DNA-based diagnostic tools.
Research Focus
Key Achievements
Top Papers
- 1